Decibel Therapeutics, Inc.

CIK 1656536 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Decibel Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2024SC 13G/A0001104659-24-023911
Oct 10, 202315-12G0001104659-23-108337
Oct 6, 2023EFFECT9999999995-23-002949
Sep 27, 2023SC 13D/A0001104659-23-104277
Sep 25, 202340000899243-23-019500
Sep 25, 202340000899243-23-019497
Sep 25, 202340000899243-23-019489
Sep 25, 2023SC 14D9/A0001193125-23-240970
Sep 25, 202340000899243-23-019490
Sep 25, 2023S-8 POS0001193125-23-240980
Sep 25, 202340000899243-23-019487
Sep 25, 202340000899243-23-019494
Sep 25, 2023POS AM0001193125-23-240973
Sep 25, 2023S-8 POS0001193125-23-240984
Sep 25, 202325-NSE0001354457-23-000695
Sep 25, 2023SC TO-T/A0001104659-23-103362
Sep 25, 202340000899243-23-019496
Sep 25, 2023S-8 POS0001193125-23-240978
Sep 25, 202340000899243-23-019498
Sep 25, 20238-K0001193125-23-240971
Sep 12, 2023SC TO-T/A0001104659-23-100041
Sep 12, 2023SC 14D9/A0001193125-23-233464
Sep 8, 2023SC TO-T/A0001104659-23-099290
Sep 8, 2023SC 14D9/A0001193125-23-231574
Aug 25, 20238-K0001193125-23-220651